Search
for
Sort by
Research 481–510 of 1000+
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Polycystic ovary syndrome and estroprogestins
- Stroke Risk Factors Unique to Women
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Black Hairy Tongue Syndrome: Case Report and Review of the Literature
- Advances in clinical applications of microneedle
- Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment
- Intradermal platelet-rich plasma for the treatment of melasma: A clinical and dermoscopic evaluation in dark skin
- Long-acting microneedle formulations
- Androgenetic Alopecia: a Review and Emerging Treatments
- Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports
- Potential Role of Cinnamon (<i>Cinnamomum verum</i>) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review
- Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome
- The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Microneedles in cosmetology: A SWOT analysis
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Cosmetic Surgery Considerations in the Female Patient
- Clinical profile and lifestyle factors in women with different severities of hirsutism
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Recurrent episodes of hair loss in a 37 year old woman
- Drug-Induced Hair Disorders
- Polycystic ovary syndrome